Quantitative DNA measurement in oropharyngeal squamous cell carcinoma and surrounding mucosa

ORL

Volumn 66, Issue 6, 2004, Pages 320-324

  Preuss, S F ^a   Brieger, J ^a   Essig, E K ^a   Stenzel, M J ^a   Mann, W J ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

DNA measurement; Genetic alterations; Head and neck squamous cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; DNA DETERMINATION; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; DNA, NEOPLASM; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; OROPHARYNGEAL NEOPLASMS; RISK FACTORS;

EID: 13244288639     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081889     Document Type: Article

References (26)

1. Boyle P, Zheng T, Macfarlane GJ, McGinn R, Maisonneuve P, LaVecchia C, Scully C: Recent advances in the etiology and epidemiology of head and neck cancer. Curr Opin Oncol 1990;2:539-545.
2. Harrison LB, Lee HJ, Pfister DG, Kraus DH, White C, Raben A, Zelefsky MJ, Strong EW, Shah JP: Long term results of primary radiotherapy with/without neck dissection for squamous cell cancer of the base of the tongue. Head Neck 1998;20:668-673.
3. Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB: Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 1993;71:452-456.
4. Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB: Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer 1994;73:187-190.
5. Jones A, Morar P, Phillips D, Field J, Husband D, Helliwell T: Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 1995;75:1343-1353.
6. Spector JG, Sessions DG, Haughey BH, Chao KS, Simpson J, El Mofty S, Perez CA: Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope 2001;111:1079-1087.
7. Sturgis E, Miller R: Second primary malignancies in the head and cancer patient. Ann Otol Rhinol Laryngol 1995;104:946-954.
8. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W, Sidransky D: Genetic progression model for head and neck cancer: Implications for field cancerization. Cancer Res 1996;56:2488-2492.
9. Bockmuhl U, Schluns K, Schmidt S, Matthias S, Petersen I: Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma. Genes Chromosomes Cancer 2002;33:29-35.
10. Welkoborsky HJ, Bernauer HS, Riazimand HS, Jacob R, Mann WJ, Hinni ML: Patterns of chromosomal aberrations in metastasizing and nonmetastasizing squamous cell carcinomas of the oropharynx and hypopharynx. Ann Otol Rhinol Laryngol 2000;109:401-410.
11. Tabor MP, Brakenhoff RH, van Houten VMM, Kummer JA, Snel MHJ, Snijders PJF, Snow GB, Leemans CR, Braakhuis BJM: Persistence of genetically altered fields in head and neck cancer patients: Biological and clinical implications. Clin Cancer Res 2001;7:1523-1532.
12. Waridel F, Estreicher A, Bron L, Flaman JM, Fontolliet C, Monnier P, Frebourg T, Iggo R: Field cancerisation and polyclonal p53 mutation in the upper aerodigestive tract. Oncogene 1997;14:163-169.
13. Tabor MP, van Houten VMM, Kummer JA, Vosjan MJWD, Vlasblom R, Snow GB, Leemans CR, Braakhuis BJM, Brakenhoff RH: Discordance of genetic alterations between primary head and neck tumors and corresponding metastases is associated with mutational status of the TP53 gene. Genes Chromosomes Cancer 2002;33:168-177.
14. Scholes AG, Woolgar JA, Boyle MA, Brown JS, Vaughan ED, Hart CA, Jones AS, Field JK: Synchronous oral carcinomas: Independent or common origin? Cancer Res 1998;58:2003-2006.
15. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, et al: Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol 2002;161:1051-1060.
16. Brieger J, Jacob R, Riazimand HS, Essig E, Heinrich UR, Bittinger F, Mann WJ: Chromosomal aberrations in premalignant and malignant squamous epithelium. Cancer Genet Cytogenet 2003;144 148-155.
17. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH: A genetic explanation of Slaughter's concept of field cancerization: Evidence and clinical implications. Cancer Res 2003;15;63:1727-1730.
18. Jacob R, Welkoborsky H, Mann W, Höfken F, Dienes H, Freije J: Heterogeneity of squamous cell carcinomas of the head and neck - Analysis of tumorbiologic factors and proliferation rates. Laryngoscope 1996;106:1170-1175.
19. Welkoborsky H, Mann W, Sanal C, Freije J: DNA measurements for monitoring chemotherapy in advanced head and neck carcinomas. Head Neck 1994;16:240-245.
20. Welkoborsky H, Mann W, Gluckman J, Freije J: Quantitative DNA measurements in malignant and benign lesions of the upper aerodigestive tract. ORL 1992;54:264-269.
21. Welkoborsky H, Mann W, Gluckman J, Freije J: Comparison of quantitative DNA measurements and cytomorphology in squamous cell carcinomas of the upper aerodigestive tract with and without lymph node metastases. Ann Otol Rhinol Laryngol 1993;102:52-57.
22. Sudbo J, Ried T, Bryne M, Kildal W, Danielsen H, Reith A: Abnormal DNA content predicts the occurrence of carcinomas in non-dysplastic oral white patches. Oral Oncol 2001;37:558-565.
23. Sudbo J, Kildal W, Johannessen AC, Koppang HS, Sudbo A, Danielsen HE, Risberg B, Reith A: Gross genomic aberrations in precancers: Clinical implications of a long-term follow-up study in oral erythroplakias. J Clin Oncol 2002;20:456-462.
24. Chung KY, Mukhopadhyay T, Kim J, et al: Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 1993;53:1676-1683.
25. Cooke LD, Cooke TG, Bootz F, Forster G, Helliwell TR, Spiller D, Stell PM: Ploidy as a prognostic indicator in end stage squamous cell carcinoma of the head and neck region treated with cisplatinum. Br J Cancer 1990;61:759-762.
26. Brennan J, Mao L, Hruban R, Boyle J, Eby Y, Koch W, Goodman S, Sidransky D: Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995;332:429-435.